Bismuth dithiocarbamate complexes as anticancer agents and beyond: a comprehensive review
Authors:
- 18 June 2025
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 54 (28) , 10830-10846
Abstract
Bismuth dithiocarbamate (Bi-DTC) complexes have emerged as promising candidates in the fight against cancer, attributed to their unique mechanisms of action and low toxicity compared to traditional metal-based therapies. With their sulfur-rich coordination sites, the dithiocarbamate (DTC) ligands facilitate versatile binding and structural diversity, enabling the formation of supramolecular assemblies with potent biological activity. While bismuth itself does not naturally exhibit biological functions, its dithiocarbamate derivatives have demonstrated notable efficacy as anticancer agents and antimicrobial and antiparasitic properties. In vitro and in vivo studies reveal that bismuth dithiocarbamates (Bi-DTC) can effectively induce apoptosis, suppress tumour growth, and overcome chemoresistance, positioning them as innovative therapeutic options. This review examines the synthesis strategies, biological mechanisms, and experimental evidence supporting the anticancer potential of these complexes. It also highlights their antimicrobial and antileishmanial activities, emphasising the role of antimicrobial properties in preventive and supportive therapies during cancer treatment. However, further investigations are essential to delineate their mechanisms of action and optimise their clinical applicability for cancer treatment.Keywords
This publication has 102 references indexed in Scilit:
- Cytotoxicity of bismuth(III) dithiocarbamate derivatives by promoting a mitochondrial-dependent apoptotic pathway and suppressing MCF-7 breast adenocarcinoma cell invasionJBIC Journal of Biological Inorganic Chemistry, 2024
- Cell‐Penetrating Peptide‐Bismuth Bicycles**Angewandte Chemie International Edition, 2024
- Synthesis, spectral characterization, and antimicrobial evaluation of new imine derived from 3‐methylthiophene‐2‐carboxaldehyde and its Co(II), Ni(II), Cu(II), and Zn(II) metal complexesApplied Organometallic Chemistry, 2021
- Bi(III) Complexes Containing Dithiocarbamate Ligands: Synthesis, Structure Elucidation by X‐ray Diffraction, Solid‐State 13 C/ 15 N NMR, and DFT CalculationsChemistrySelect, 2020
- Chelators for copper radionuclides in positron emission tomography radiopharmaceuticalsJournal of Labelled Compounds and Radiopharmaceuticals, 2013
- Synthetic, spectral as well as in vitro antimicrobial studies on some bismuth(III) bis(N,N‐dialkyldithiocarbamato) alkylenedithiophosphatesApplied Organometallic Chemistry, 2010
- Crystallographic report: Bis[(nitro)bis(dithiotetrahydropyrrolocarbamato) bismuth(III)]Applied Organometallic Chemistry, 2005
- Crystallographic report: Bis[tris(morpholindithiocarbamato)bismuth(III)]Applied Organometallic Chemistry, 2004
- Crystallographic report: Bis[bis(N‐methyl‐N‐phenyldithiocarbamato)‐(methylxanthato)bismuth(III)]Applied Organometallic Chemistry, 2004
- The properties of dithiocarbamates A ReviewMicrochimica Acta, 1969